- call +1-201-465-4211
- email sales@mrinsights.biz
A congenital heart disease is a problem in the structure of the heart that is present at birth.
Scope of the Report:
The factors driving the growth of the global congenital heart disease market are rising prevalence of congenital heart disease and rise in adoption of minimally invasive procedures. Further, large number of dominating market players, growing demand for catheterization and application of cardiac biomarkers in congenital heart disease treatment are also considered as a major factor for driving the growth of the global congenital heart disease market during forecast period.
The global Congenital Heart Disease market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Congenital Heart Disease.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Congenital Heart Disease market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Congenital Heart Disease market by product type and applications/end industries.
Market Segment by Companies, this report covers
Abbott Diagnostics
Array BioPharma
AstraZeneca
Becton Dickinson
BG Medicine
Bio-Rad
Boston Scientific
Covance
Critical Diagnostics
Roche
GSK
Janssen Pharmaceuticals
Medtronic
Merck
Mylan
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Medications
Implantable heart devices
Catheter procedures
Open-heart surgery
Heart transplant
Market Segment by Applications, can be divided into
Hospitals and clinics
Diagnostic centres
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Congenital Heart Disease Market Overview
1.1 Product Overview and Scope of Congenital Heart Disease
1.2 Classification of Congenital Heart Disease by Types
1.2.1 Global Congenital Heart Disease Revenue Comparison by Types (2017-2023)
1.2.2 Global Congenital Heart Disease Revenue Market Share by Types in 2017
1.2.3 Medications
1.2.4 Implantable heart devices
1.2.5 Catheter procedures
1.2.6 Open-heart surgery
1.2.7 Heart transplant
1.3 Global Congenital Heart Disease Market by Application
1.3.1 Global Congenital Heart Disease Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals and clinics
1.3.3 Diagnostic centres
1.4 Global Congenital Heart Disease Market by Regions
1.4.1 Global Congenital Heart Disease Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Congenital Heart Disease Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Congenital Heart Disease Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Congenital Heart Disease Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Congenital Heart Disease Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Congenital Heart Disease Status and Prospect (2013-2023)
1.5 Global Market Size of Congenital Heart Disease (2013-2023)
2 Manufacturers Profiles
2.1 Abbott Diagnostics
2.1.1 Business Overview
2.1.2 Congenital Heart Disease Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Diagnostics Congenital Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.2 Array BioPharma
2.2.1 Business Overview
2.2.2 Congenital Heart Disease Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Array BioPharma Congenital Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.3 AstraZeneca
2.3.1 Business Overview
2.3.2 Congenital Heart Disease Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AstraZeneca Congenital Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.4 Becton Dickinson
2.4.1 Business Overview
2.4.2 Congenital Heart Disease Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Becton Dickinson Congenital Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.5 BG Medicine
2.5.1 Business Overview
2.5.2 Congenital Heart Disease Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 BG Medicine Congenital Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.6 Bio-Rad
2.6.1 Business Overview
2.6.2 Congenital Heart Disease Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Bio-Rad Congenital Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.7 Boston Scientific
2.7.1 Business Overview
2.7.2 Congenital Heart Disease Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Boston Scientific Congenital Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.8 Covance
2.8.1 Business Overview
2.8.2 Congenital Heart Disease Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Covance Congenital Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.9 Critical Diagnostics
2.9.1 Business Overview
2.9.2 Congenital Heart Disease Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Critical Diagnostics Congenital Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.10 Roche
2.10.1 Business Overview
2.10.2 Congenital Heart Disease Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Roche Congenital Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.11 GSK
2.11.1 Business Overview
2.11.2 Congenital Heart Disease Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 GSK Congenital Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.12 Janssen Pharmaceuticals
2.12.1 Business Overview
2.12.2 Congenital Heart Disease Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Janssen Pharmaceuticals Congenital Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.13 Medtronic
2.13.1 Business Overview
2.13.2 Congenital Heart Disease Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Medtronic Congenital Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.14 Merck
2.14.1 Business Overview
2.14.2 Congenital Heart Disease Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Merck Congenital Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
2.15 Mylan
2.15.1 Business Overview
2.15.2 Congenital Heart Disease Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Mylan Congenital Heart Disease Revenue, Gross Margin and Market Share (2016-2017)
3 Global Congenital Heart Disease Market Competition, by Players
3.1 Global Congenital Heart Disease Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Congenital Heart Disease Players Market Share
3.2.2 Top 10 Congenital Heart Disease Players Market Share
3.3 Market Competition Trend
4 Global Congenital Heart Disease Market Size by Regions
4.1 Global Congenital Heart Disease Revenue and Market Share by Regions
4.2 North America Congenital Heart Disease Revenue and Growth Rate (2013-2018)
4.3 Europe Congenital Heart Disease Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Congenital Heart Disease Revenue and Growth Rate (2013-2018)
4.5 South America Congenital Heart Disease Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Congenital Heart Disease Revenue and Growth Rate (2013-2018)
5 North America Congenital Heart Disease Revenue by Countries
5.1 North America Congenital Heart Disease Revenue by Countries (2013-2018)
5.2 USA Congenital Heart Disease Revenue and Growth Rate (2013-2018)
5.3 Canada Congenital Heart Disease Revenue and Growth Rate (2013-2018)
5.4 Mexico Congenital Heart Disease Revenue and Growth Rate (2013-2018)
6 Europe Congenital Heart Disease Revenue by Countries
6.1 Europe Congenital Heart Disease Revenue by Countries (2013-2018)
6.2 Germany Congenital Heart Disease Revenue and Growth Rate (2013-2018)
6.3 UK Congenital Heart Disease Revenue and Growth Rate (2013-2018)
6.4 France Congenital Heart Disease Revenue and Growth Rate (2013-2018)
6.5 Russia Congenital Heart Disease Revenue and Growth Rate (2013-2018)
6.6 Italy Congenital Heart Disease Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Congenital Heart Disease Revenue by Countries
7.1 Asia-Pacific Congenital Heart Disease Revenue by Countries (2013-2018)
7.2 China Congenital Heart Disease Revenue and Growth Rate (2013-2018)
7.3 Japan Congenital Heart Disease Revenue and Growth Rate (2013-2018)
7.4 Korea Congenital Heart Disease Revenue and Growth Rate (2013-2018)
7.5 India Congenital Heart Disease Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Congenital Heart Disease Revenue and Growth Rate (2013-2018)
8 South America Congenital Heart Disease Revenue by Countries
8.1 South America Congenital Heart Disease Revenue by Countries (2013-2018)
8.2 Brazil Congenital Heart Disease Revenue and Growth Rate (2013-2018)
8.3 Argentina Congenital Heart Disease Revenue and Growth Rate (2013-2018)
8.4 Colombia Congenital Heart Disease Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Congenital Heart Disease by Countries
9.1 Middle East and Africa Congenital Heart Disease Revenue by Countries (2013-2018)
9.2 Saudi Arabia Congenital Heart Disease Revenue and Growth Rate (2013-2018)
9.3 UAE Congenital Heart Disease Revenue and Growth Rate (2013-2018)
9.4 Egypt Congenital Heart Disease Revenue and Growth Rate (2013-2018)
9.5 Nigeria Congenital Heart Disease Revenue and Growth Rate (2013-2018)
9.6 South Africa Congenital Heart Disease Revenue and Growth Rate (2013-2018)
10 Global Congenital Heart Disease Market Segment by Type
10.1 Global Congenital Heart Disease Revenue and Market Share by Type (2013-2018)
10.2 Global Congenital Heart Disease Market Forecast by Type (2018-2023)
10.3 Medications Revenue Growth Rate (2013-2023)
10.4 Implantable heart devices Revenue Growth Rate (2013-2023)
10.5 Catheter procedures Revenue Growth Rate (2013-2023)
10.6 Open-heart surgery Revenue Growth Rate (2013-2023)
10.7 Heart transplant Revenue Growth Rate (2013-2023)
11 Global Congenital Heart Disease Market Segment by Application
11.1 Global Congenital Heart Disease Revenue Market Share by Application (2013-2018)
11.2 Congenital Heart Disease Market Forecast by Application (2018-2023)
11.3 Hospitals and clinics Revenue Growth (2013-2018)
11.4 Diagnostic centres Revenue Growth (2013-2018)
12 Global Congenital Heart Disease Market Size Forecast (2018-2023)
12.1 Global Congenital Heart Disease Market Size Forecast (2018-2023)
12.2 Global Congenital Heart Disease Market Forecast by Regions (2018-2023)
12.3 North America Congenital Heart Disease Revenue Market Forecast (2018-2023)
12.4 Europe Congenital Heart Disease Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Congenital Heart Disease Revenue Market Forecast (2018-2023)
12.6 South America Congenital Heart Disease Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Congenital Heart Disease Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Congenital Heart Disease Picture
Table Product Specifications of Congenital Heart Disease
Table Global Congenital Heart Disease and Revenue (Million USD) Market Spli
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
